Maryam has been working on stem cell biology and oncology for the past 9 years during her postdoctoral training with Dr. Monte Winslow at Stanford University, Ph.D. with Dr. Christopher Lengner at the University of Pennsylvania, and M.S.c. at the University of Tehran. Her extensive experience includes the use of genetically engineered mouse models, Next-Generation Sequencing, pharmacogenomic analysis, and CRISPR/Cas9 genome editing to discover molecular pathways regulating stem cell self-renewal, tissue regeneration, tumor initiation, and drug response. She has been using this knowledge to regulate these pathways pharmacologically and using environmental cues such as nutrient modulation and calorie restriction to achieve desirable outcomes such as protection of epithelial tissues against injuries frequently caused by conventional cancer treatments such as radiotherapy. Her long-term career goal is to use her rigorous training in molecular biology, regenerative medicine, and oncology to design efficient and safe drugs for cancer therapy.